Jan 13, 2021 09:17AM
Jan 13, 2021 09:15AM
Aug 6, 2020 04:02PM
Jun 5, 2020 09:23AM
Jun 5, 2020 07:46AM
Jun 4, 2020 05:26PM
Jun 4, 2020 04:31PM Adamas Pharma (ADMS) announces FDA filing acceptance of sNDA to modify indication statement for GOCOVRI to include treatment for Parkinson’s disease patients receiving levodopa and experiencing OFF
Jun 4, 2020 04:30PM
Aug 24, 2017 11:59AM
Aug 24, 2017 10:45AM
Aug 24, 2017 08:54AM
Aug 8, 2017 04:01PM
Aug 1, 2017 02:34PM
Jul 10, 2017 04:33PM Adamas Reports Inducement Grant to New Chief Financial Officer
Jun 28, 2017 09:01AM
Jun 28, 2017 09:00AM
Jun 12, 2017 04:03PM
Jun 12, 2017 04:01PM
Jun 8, 2017 04:12PM
Jun 8, 2017 04:10PM
Jun 1, 2017 12:31PM Adamas to Present at Two Upcoming Investor Conferences
May 22, 2017 08:48AM
May 22, 2017 08:30AM
May 11, 2017 09:12AM
May 9, 2017 04:01PM
May 5, 2017 05:43PM
May 2, 2017 04:07PM
Apr 27, 2017 05:51PM Adamas Appoints Richard A. King as Chief Operating Officer to Lead Commercialization of ADS-5102
Apr 24, 2017 09:09AM
Apr 24, 2017 09:06AM
Apr 18, 2017 12:08PM
Mar 28, 2017 02:03PM
Mar 28, 2017 01:39PM
Mar 28, 2017 10:33AM
Mar 15, 2017 01:05PM Adamas Pharmaceuticals (ADMS) Remains Top Pick at Mizuho Into August 24 PDUFA
Mar 10, 2017 04:34PM
Mar 1, 2017 02:44PM
Feb 28, 2017 04:05PM
Feb 28, 2017 08:38AM
Feb 28, 2017 08:30AM
Feb 21, 2017 05:49AM
Feb 17, 2017 08:00AM Adamas to Present New ADS-5102 Data from Phase 2 Trial in Walking Impairment Associated with Multiple Sclerosis at ACTRIMS Forum 2017
Jan 8, 2017 07:57PM
Jan 6, 2017 09:01AM
Jan 6, 2017 09:00AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All